| Literature DB >> 27532610 |
Laura Brugnara1,2, Serafín Murillo1,2, Anna Novials1,2, Gemma Rojo-Martínez1,3, Federico Soriguer1,3, Albert Goday4, Alfonso Calle-Pascual5, Luis Castaño1,6, Sonia Gaztambide1,6, Sergio Valdés1,3, Josep Franch7, Conxa Castell8, Joan Vendrell1,9, Roser Casamitjana1,2, Anna Bosch-Comas1,2, Elena Bordiú5, Rafael Carmena1,10, Miguel Catalá1,10, Elias Delgado11, Juan Girbés12, Alfonso López-Alba13, Maria Teresa Martínez-Larrad1,14, Edelmiro Menéndez11, Inmaculada Mora-Peces15, Gemma Pascual-Manich1,2, Manuel Serrano-Ríos1,16, Ramon Gomis1,2, Emilio Ortega14,17.
Abstract
Low physical activity (PA), or sedentary lifestyle, is associated with the development of several chronic diseases. We aimed to investigate current prevalence of sedentariness and its association with diabetes and other cardiovascular risk factors. PA was evaluated in a population-based, cross-sectional, randomly sampled study conducted in 2009-2010 in Spain. International Physical Activity Questionnaire (SF-IPAQ) was used to assess PA. 4991 individuals (median age 50 years, 57% women) were studied. Prevalence of sedentariness was 32.3% for men and 39% for women (p < 0.0001). Sex differences were particularly notable (age*sex interaction, p = 0.0024) at early and older ages. Sedentary individuals had higher BMI (28 vs. 27 kg/m2) and obesity prevalence (37 vs. 26%). Low PA was present in 44, 43, and 38% of individuals with known diabetes (KDM), prediabetes/unknown-diabetes (PREDM/UKDM), and normal glucose regulation (p = 0.0014), respectively. No difference between KDM and PREDM/UKDM (p = 0.72) was found. Variables independently associated (p < 0.05) with sedentariness were age, sex, BMI, central obesity, Mediterranean diet adherence, smoking habit, HDL-cholesterol, triglycerides and dyslipidemia. Low PA is on the rise in Spain, especially among women. Sedentariness is associated with several cardiovascular risk factors and may be responsible for the increasing prevalence of obesity and diabetes in this country.Entities:
Mesh:
Year: 2016 PMID: 27532610 PMCID: PMC4988632 DOI: 10.1371/journal.pone.0160959
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Prevalence of sedentariness, or low physical activity, in Spain.
Prevalence was adjusted to the age and sex structure of the Spanish population. *Data from the 2002–2003 report by Sjöström M et al in 2006 [3].
Fig 2Prevalence of sedentariness and obesity in men and women in Spain.
Data adjusted to the age and sex structure of the Spanish population (INE 2016) [5]. BMI, body mass index.
Physical activity in women and men.
| Women | Men | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age group (years) | 18-30(n = 334) | 31-45(n = 810) | 46–60 (n = 823) | 61–75 (n = 613) | >75 (n = 284) | All(n = 2864) | 18–30 (n = 260) | 31–45 (n = 594) | 46–60 (n = 542) | 61–75 (n = 519) | >75(n = 212) | All(n = 2127) |
| No physical activity at all | 32 (10) | 61 (8) | 66 (8) | 56 (9) | 52 (18) | 264 (9) | 8 (3) | 43 (7) | 49 (9) | 17 (3) | 17 (8) | 134 (6) |
| Walking activity at least 10 min once a week | 287 (86) | 719 (89) | 739 (90) | 553 (90) | 230 (81) | 2528 (88) | 219 (84) | 506 (85) | 470 (87) | 490 (94) | 192 (91) | 1877 (88) |
| MET-min/week, median (p25th -p75th) | 396(231–792) | 594(297–1188) | 594(264–1040) | 594(330–1386) | 594(297–1040) | 594(297–1040) | 495(248–1040) | 495(248–990) | 627(297–1188) | 990(462–1386) | 990(478–1386) | 693(330–1386) |
| Walking time, min/week, median (p25th -p75th) | 120(70–240) | 180(90–360) | 180(80–315) | 180(100–420) | 180(90–315) | 180(90–315) | 150(75–315) | 150(75–300) | 190(90–360) | 300(140–420) | 300(145–420) | 210(100–420) |
| MVPA at least once a week | 146 (44) | 365 (45) | 319 (39) | 200 (33) | 61 (22) | 1091 (38) | 202 (78) | 320 (54) | 232 (43) | 204 (39) | 63 (30) | 1021 (48) |
| MET-min/ week, median (p25th -p75th) | 840(480–1920) | 960(480–1680) | 960(480–1920) | 720(380–1680) | 720(240–1680) | 960(480–1800) | 1440(720–3000) | 1200(480–2880) | 1440(480–2580) | 960(480–1920) | 960(320–2400) | 1200(480–2400) |
| MVPA time, min/week, median (p25th -p75th) | 165(60–300) | 180(90–360) | 210(120–480) | 180(90–420) | 180(60–420) | 180(90–360) | 240(100–480) | 180(85–412) | 240(108–450) | 210(113–420) | 210(70–540) | 210(90–435) |
| 693(248–1536) | 834(330–1695) | 693(297–1533) | 693(297–1485) | 498(148–1188) | 693(297–1506) | 1542(693–3329) | 988(346–2430) | 883(346–2141) | 1386(594–2190) | 1093(404–2079) | 1150(446–2400) | |
| Total PA min/week, median (p25th -p75th) | 180(70–380) | 212(100–420) | 210(90–420) | 210(90–430) | 150(45–360) | 210(80–420) | 330(140–660) | 210(90–540) | 227(100–560) | 360(170–630) | 300(120–630) | 290(120–600) |
| > 1000 MET-min/week of physical activity, n (%) | 126 (38) | 362 (45) | 328 (40) | 240 (39) | 82 (29) | 1138 (40) | 169 (65) | 288 (48) | 249 (46) | 298 (57) | 110 (52) | 1114 (52) |
Data are number of individuals and percentage or median and interquartile range
a Data from individuals walking at least 10 minutes once a week
b Data from individuals performing MVPA at least once a week
c Health & Human Services 2008 recommendation [13]
† p<0.001 for sex differences
Subjects’ clinical and laboratory characteristics according to physical activity.
| Physical activity | |||
|---|---|---|---|
| Sedentary (n = 1945) | Active (n = 3046) | p | |
| 721 (37) | 803 (26) | <0.0001 | |
| BMI (kg/m2) | 28.2 (24.8–31.9) | 27.1 (24.2–30.3) | <0.0001 |
| Central obesity (n,%) | 921 (48) | 1122 (37) | <0.0001 |
| Waist circumference (cm) | 96 (86–106) | 93 (83–102) | <0.0001 |
| 510 (26) | 665 (22) | 0.0004 | |
| On 1 antihypertensive drug (n,%) | 265 (14) | 399 (13) | 0.5939 |
| On > 1 antihypertensive drugs (n,%) | 200 (10) | 250 (8) | 0.0125 |
| Systolic blood pressure (mm Hg) | 130 (116.5–144.3) | 130 (117–144.3) | 0.6856 |
| Diastolic blood pressure (mm Hg) | 76.5 (70–84) | 76.5 (69.6–83.5) | 0.2345 |
| 702 (37) | 951 (32) | 0.0004 | |
| On lipid lowering medication (n,%) | 278 (14) | 397 (13) | 0.2045 |
| On statins (n,%) | 219 (11) | 358 (12) | 0.5949 |
| Atherogenic dyslipidemia (n,%) | 200 (11) | 224 (8) | 0.0003 |
| Total-cholesterol (mg/dL) | 196 (169–222) | 195 (167–222) | 0.4717 |
| HDL-cholesterol (mg/dL) | 49 (42–58) | 51 (43–60) | 0.0026 |
| Triglycerides (mg/dL) | 108 (78–148) | 99 (73–136) | <0.0001 |
| 94 (86–105) | 93 (85–103) | 0.0057 | |
| HOMA-IR | 2.03 (1.36–3.21) | 1.74 (1.20–2.60) | <0.0001 |
| On diabetes medication (n,%) | 176 (9) | 233 (8) | 0.0788 |
| On insulin treatment (n,%) | 40 (2) | 40 (1) | 0.0414 |
| 788 (41) | 1025 (34) | <0.0001 | |
| 540 (28) | 745 (25) | 0.0089 | |
| 279 (14) | 507 (17) | 0.0301 | |
Data are number of individuals and percentage or median and interquartile range. P-values for group differences are given
a Central obesity: waist / hip ratio ≥ 1 in men, ≥ 0.85 in women
b Missing data for antihypertensive drugs n = 61
c Atherogenic dyslipidemia: triglycerides > 150 mg/dl and HDL-cholesterol < 50 mg/dl for women or < 40 mg/dl for men
Physical activity in carbohydrate metabolism status.
| NORMAL(N = 3771) | PREDM/UKDM (N = 808) | KDM(N = 472) | * p value | † Age-sex-BMIadj p-value | |
|---|---|---|---|---|---|
| Age (years) | 45 (34–58) | 61 (51–72) | 66 (59–74) | <0.0001 | - |
| Male sex, n (%) | 1483 (40) | 404 (50) | 240 (51) | <0.0001 | - |
| BMI (kg/m2) | 26.6 (23.8–29.8) | 30.3 (27.3–33.4) | 30.2 (27.1–33.3) | <0.0001 | - |
| No physical activity at all, n (%) | 248 (7) | 82 (10) | 68 (14)* | <0.0001 | <0.0001 |
| 1392 (38) | 346 (43) | 207 (44) | 0.0014 | 0.0160 | |
| Walking activity at least 10 min once a week | 3308 (89) | 706 (87) | 391 (83) | 0.0002 | <0.0001 |
| MET-min/week, median (p25th -p75th) | 594 (297–1188) | 693 (297–1386) | 693 (330–1386) | 0.0255 | 0.7927 |
| Total time, min/week,median (p25th -p75th) | 180 (90–360) | 210 (90–420) | 210 (100–420) | 0.0255 | 0.7926 |
| MVPA at least once a week | 1703 (46) | 274 (34) | 135 (29) | <0.0001 | 0.0258 |
| MET-min/week, median (p25th -p75th) | 960 (480–2320) | 960 (480–1920) | 960 (400–1920) | 0.0929 | 0.2132 |
| Total time, min/week,median (p25th -p75th) | 180 (90–420) | 180 (90–420) | 240 (90–360) | 0.9965 | 0.2705 |
| 932 (358–2020) | 718 (297–1615) | 693 (231–1628) | <0.0001 | 0.1544 | |
| Total PA min/week,median (p25th -p75th) | 230 (100–480) | 210 (80–433) | 210 (70–450) | 0.0014 | 0.2770 |
| > 1000 MET-min/week of physical activity (%) | 1719 (46) | 344 (43) | 189 (40) | 0.0101 | 0.1771 |
Data are number of individuals and percentage or median and interquartile range. P-values for groups differences before (*) and after (†) adjustment for age, sex, and BMI (body mass index) are given. NORMAL: normal glucose metabolism; PREDM/UKDM: prediabetes and unknown diabetes; KDM: known diabetes
a Data from individuals walking at least 10 minutes once a week
b Data from individuals performing MVPA at least once a week
c No difference between PREDM/UKDM and KDM (p = 0.72)
Variables associated with sedentariness, or low physical activity.
| OR (95% CI) | |
|---|---|
| Age (5 years increment) | 0.98 (0.95–0.99) |
| Male sex | 0.63 (0.55–0.73) |
| BMI (5 units kg/m2 increment) | 1.23 (1.15–1.31) |
| Central obesity (WHR ≥1m men; ≥0.85m women) | 1.20 (1.04–1.40) |
| Dyslipidemia | 1.16 (1.01–1.32) |
| Hypertension | 1.15 (0.97–1.37) |
| HDL-cholesterol (5 mg/dl increment) | 0.97 (0.94–0.99) |
| Triglycerides (10 mg/dl increment) | 1.01 (1.00–1.02) |
| Adherence to Mediterranean Diet (2nd-3rd tercile vs.1st tercile) | 0.74 (0.65–0.84) |
| Active smoker | 1.25 (1.08–1.44) |
Data are OR (95% CI) for the association between the variables indicated and physical activity. Multiple logistic regression model (stepwise), level of sig. for entry p = 0.15. Dependent variable: sedentariness, or low physical activity (low vs. moderate/vigorous). Independent variables considered in the model were age, sex, BMI (kg/m2), central obesity (waist/hip ratio ≥ 1 in men, ≥ 0.85 in women), carbohydrate metabolism (NORMAL, PREDM/UKDM, KDM), active smoking, hypertension, dyslipidemia, university studies, Mediterranean diet adherence, HDL-cholesterol (mg/dl), triglycerides (mg/dl), systolic and diastolic blood pressures (mmHg), insulin use, and > 1 hypertensive drug use.